7-41961971-TA-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_000168.6(GLI3):​c.*2358delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0301 in 136,184 control chromosomes in the GnomAD database, including 65 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.030 ( 65 hom., cov: 32)
Exomes 𝑓: 0.17 ( 0 hom. )

Consequence

GLI3
NM_000168.6 3_prime_UTR

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -0.972

Publications

0 publications found
Variant links:
Genes affected
GLI3 (HGNC:4319): (GLI family zinc finger 3) This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI3 Gene-Disease associations (from GenCC):
  • Greig cephalopolysyndactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Pallister-Hall syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics, Orphanet
  • polydactyly, postaxial, type A1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • polysyndactyly 4
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • tibial hemimelia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acrocallosal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postaxial polydactyly type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 7-41961971-TA-T is Benign according to our data. Variant chr7-41961971-TA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 360170.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=3, Likely_benign=1}.
BA1
GnomAdExome4 highest population allele frequency = 0.167 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI3NM_000168.6 linkc.*2358delT 3_prime_UTR_variant Exon 15 of 15 ENST00000395925.8 NP_000159.3 P10071

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI3ENST00000395925.8 linkc.*2358delT 3_prime_UTR_variant Exon 15 of 15 5 NM_000168.6 ENSP00000379258.3 P10071
GLI3ENST00000677605.1 linkc.*2358delT 3_prime_UTR_variant Exon 15 of 15 ENSP00000503743.1 P10071
GLI3ENST00000678429.1 linkc.*2358delT 3_prime_UTR_variant Exon 15 of 15 ENSP00000502957.1 P10071
GLI3ENST00000677288.1 linkc.*2358delT 3_prime_UTR_variant Exon 14 of 14 ENSP00000503986.1 A0A7I2V4X9

Frequencies

GnomAD3 genomes
AF:
0.0301
AC:
4097
AN:
136108
Hom.:
65
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0203
Gnomad AMI
AF:
0.0133
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.0380
Gnomad EAS
AF:
0.00313
Gnomad SAS
AF:
0.0102
Gnomad FIN
AF:
0.0511
Gnomad MID
AF:
0.0140
Gnomad NFE
AF:
0.0389
Gnomad OTH
AF:
0.0243
GnomAD4 exome
AF:
0.167
AC:
1
AN:
6
Hom.:
0
Cov.:
0
AF XY:
0.167
AC XY:
1
AN XY:
6
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0301
AC:
4101
AN:
136178
Hom.:
65
Cov.:
32
AF XY:
0.0302
AC XY:
1987
AN XY:
65780
show subpopulations
African (AFR)
AF:
0.0203
AC:
754
AN:
37058
American (AMR)
AF:
0.0200
AC:
273
AN:
13628
Ashkenazi Jewish (ASJ)
AF:
0.0380
AC:
122
AN:
3214
East Asian (EAS)
AF:
0.00335
AC:
16
AN:
4780
South Asian (SAS)
AF:
0.0104
AC:
44
AN:
4224
European-Finnish (FIN)
AF:
0.0511
AC:
418
AN:
8184
Middle Eastern (MID)
AF:
0.0153
AC:
4
AN:
262
European-Non Finnish (NFE)
AF:
0.0389
AC:
2413
AN:
62098
Other (OTH)
AF:
0.0241
AC:
46
AN:
1906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
195
391
586
782
977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
1
Bravo
AF:
0.0250

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Greig cephalopolysyndactyly syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polydactyly Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pallister-Hall syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 12, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.97
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144064690; hg19: chr7-42001569; COSMIC: COSV67884926; COSMIC: COSV67884926; API